IRCT201512081556N83已完成未知
Carnosine added to risperidone in the treatment of Autism: A double blind and placebo controlled trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 3 years 至 12 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria: 1-DSM-5 clinical diagnosis of autistic disorder, 2-children between the ages of 3 and 12 years ,3- presence of behavioral problems such as aggression, overactivity or repetitive behaviors (indication of treatment with risperidone)
排除标准
- •1- Presence of any active medical problem, 2-any diagnosis in Axis I and II except for mental retardation, 3- receiving any psychotropic medications during past two weeks prior to the trial, 5-presence of hepatic disease, 6-history of seizure
研究者
相似试验
已完成
不适用
Carnosine in the treatment of OCDObsessive- Cumpulsive Disorder.Obsessive-compulsive disorderIRCT201604201556N88Tehran University of Medical Sciences50
已完成
3 期
carnosine in SchizophreniaCTRI/2019/02/017646Brio Bliss life science pvtltd100
已完成
2 期
Riluzole in the treatment of autismChildhood autism.Childhood autismIRCT201107281556N27Tehran University of Medical Sciences40
已完成
不适用
Carnosine added to risperidone in the treatment of ADHD: A double blind and placebo controlled trialDisturbance of activity and attention.Disturbance of activity and attentionIRCT201601031556N84Tehran University of Medical Sciences50
已完成
3 期
carnosine in patients with schizophreniaschizophrenia.schizophreniaIRCT201504211556N75Tehran University of Medical Sciences50